Sort
48,018 grants matching “immunotherapy”
Targeting telomerase for melanoma therapeutics
$471,448Emmanuel Skordalakes · Wistar Institute · R01 · FY2018 · CA
Development of lung T cell responses in infant respiratory immunity
$471,432Donna L Farber · Columbia University Health Sciences · R01 · FY2016 · AI
Development of lung T cell responses in infant respiratory immunity
$471,432Donna L Farber · Columbia University Health Sciences · R01 · FY2014 · AI
Development of lung T cell responses in infant respiratory immunity
$471,432Donna L Farber · Columbia University Health Sciences · R01 · FY2012 · AI
Targeting innate immune pathways in breast cancers with chromosomal instability
$471,423Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Immunoengineering Postdoctoral Training Program - Resubmission - 1
$471,388Melody A Swartz · University Of Chicago · T32 · FY2023 · AI
Function of IL35+ B cells in pancreatic cancer
$471,387Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2020 · CA
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
$471,315Yong Wan · Emory University · R01 · FY2024 · CA
Negative regulation of myeloid-derived suppressive cells in cancer
$471,244Yulia Nefedova · Wistar Institute · R01 · FY2021 · CA
Characterization of Pigmentary Disorders and Melanoma Targeting
$471,189Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Molecular Basis of Parvoviral Target Cell Specificity
$471,184Peter Tattersall · Yale University · R01 · FY2007 · CA
Engineering Nanomaterials to Prime Immunity
$471,122James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Basophil phenotype & activation in peanut allergy and oral Immunotherapy
$471,113Stephen J Galli · Stanford University · U19 · FY2017 · AI
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$471,003Sidi A Bencherif · Northeastern University · R01 · FY2022 · EB
ROLE OF T CELLS IN THE IMMUNE MODULATION OF MS
$471,000Nitin J Karandikar · Ut Southwestern Medical Center · R01 · FY2009 · AI
Interplay between tumor and microenvironment in bone metastasis
$470,956Paul B Fisher · Virginia Commonwealth University · R01 · FY2021 · CA
Interplay between tumor and microenvironment in bone metastasis
$470,956Paul B Fisher · Virginia Commonwealth University · R01 · FY2025 · CA
Development of Immunologic therapies against uveitis
$470,940Charles E Egwuagu · National Eye Institute · ZIA · FY2019 · EY
Antibody Engineering Program
$470,858Mitchell Ho · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Linking allergen-specific T cell effector and regulatory responses to asthma
$470,816Andrew D Luster · Massachusetts General Hospital · U19 · FY2012 · AI
Validation and Application of a Model for Human-like TB Latency in Rabbits
$470,784David Alland · Rbhs-New Jersey Medical School · U19 · FY2019 · AI
Immune regulation of tissue iron in health and disease
$470,750Nicholas J. Bessman · Rbhs-New Jersey Medical School · DP2 · FY2021 · AI
Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex
$470,741Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2020 · GM
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatory T-regulatory cells
$470,682Fotini Gounari · University Of Chicago · R01 · FY2015 · AI
The differentiation and function of CD4+ Th2 cells during allergen-induced asthma
$470,649Marion Pepper · University Of Washington · R01 · FY2016 · AI